Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Toby Odenheim, MBA

Director, Technology and Governance

Informatics

Biography

In his current role as director of technology and governance at PICI, Toby Odenheim, MBA, leads an array of technology and process improvement initiatives aimed at accelerating the development of innovative cancer immunotherapy treatments. Core areas of oversight include management of clinical and pharmacovigilance systems, including CTMS, eTMF, IRT, EDC, ePRO, Medical Coding, Safety, and Business Intelligence systems.

Prior to joining PICI, Odenheim was the founder and principal at Odin Life Sciences Consulting, where he guided companies in the selection, implementation and validation of best-of-breed clinical technologies. Additionally, he led process optimization initiatives within IT and Data Management. Odenheim has held management positions at Gilead, Synteract, ClinicalSoft and Pfizer.

Education background includes an undergraduate degree in biology from the University of Virginia, an MBA from CSUDH, and professional certifications from UCSD in finance, oracle database administration and relational database design.